<![CDATA[Transmucosal Patch Yields Pathologic Responses in Non-Invasive Oral Cancer]]>

Data ReadoutpositivePRV111Positive

AI Analysis

Summary

PRV111, a transmucosal patch, achieved pathologic responses and eliminated planned surgery in 100% of evaluable patients with non-invasive oral cancer or high-grade dysplasia.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

PRV111 eliminated planned surgery in 100% of evaluable patients with non-invasive oral cancer or high-grade dysplasia

Importance:6/10

Sentiment:

0.80

oral cancertransmucosal patchpathologic responsedysplasiasurgery elimination

Related Companies

$LLY

Read the original article

Published by Cancer Network on October 7, 2026 4:00 PM

Read Original